Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
The Medication Adherence Epidemic: How To Keep Patients Healthy, Aditya Loganathan, Ishan S. Abdullah, Randall W. Lee
The Medication Adherence Epidemic: How To Keep Patients Healthy, Aditya Loganathan, Ishan S. Abdullah, Randall W. Lee
URGENT Matters
No abstract provided.
Medication Adherence And Its Implications For Clinical Research: An Example From Low Income, Urban Young Adults Living With Hiv/Aids, Kathleen A. Thoma
Medication Adherence And Its Implications For Clinical Research: An Example From Low Income, Urban Young Adults Living With Hiv/Aids, Kathleen A. Thoma
Clinical Research and Leadership Faculty Posters and Presentations
Consistent medication adherence by study participants is essential for producing valid and reliable safety and efficacy data in clinical trials. Adherence to investigational medications can be a challenge, particularly for study participants who have complex medication regimens, a stigmatized illness such as HIV/AIDS or a mental health disorder, and risk factors for poor adherence such as young or old age, poor health status, cognitive issues, low health literacy, and low socioeconomic status. A deep understanding of the study population’s beliefs, attitudes, motivations, and prior experiences regarding medication adherence can assist clinical research professionals with predicting medication adherence potential during the …
True Durability: Hiv Virologic Suppression In An Urban Clinic And Implications For Timing Of Intensive Adherence Efforts And Viral Load Monitoring., Debra A Benator, Angelo Elmi, Manuel D Rodriguez, Howard B Gale, Virginia L. Kan, Heather J. Hoffman, Susan Tramazzo, Karen Hall, Angela Mcknight, Leah Squires
True Durability: Hiv Virologic Suppression In An Urban Clinic And Implications For Timing Of Intensive Adherence Efforts And Viral Load Monitoring., Debra A Benator, Angelo Elmi, Manuel D Rodriguez, Howard B Gale, Virginia L. Kan, Heather J. Hoffman, Susan Tramazzo, Karen Hall, Angela Mcknight, Leah Squires
Medicine Faculty Publications
Although the majority of HIV-infected patients who begin potent antiretroviral therapy should expect long-term virologic suppression, the realities in practice are less certain. Durability of viral suppression was examined to define the best timing of targeted adherence strategies and intensive viral load monitoring in an urban clinic population with multiple challenges to ART adherence. We examined the risk of viral rebound for patients who achieved two consecutive viral loads lower than the lower limit of quantification (LLOQ) within 390 days. For 791 patients with two viral loads below the LLOQ, viral rebound >LLOQ from the first viral load was 36.9 …
True Durability: Hiv Virologic Suppression In An Urban Clinic And Implications For Timing Of Intensive Adherence Efforts And Viral Load Monitoring, Debra A. Benator, Angelo Elmi, Manuel D. Rodriguez, Howard B. Gale, Virginia L. Kan, Heather J. Hoffman, Susan Tramazzo, Karen Hall, Angela Mcknight, Leah Squires
True Durability: Hiv Virologic Suppression In An Urban Clinic And Implications For Timing Of Intensive Adherence Efforts And Viral Load Monitoring, Debra A. Benator, Angelo Elmi, Manuel D. Rodriguez, Howard B. Gale, Virginia L. Kan, Heather J. Hoffman, Susan Tramazzo, Karen Hall, Angela Mcknight, Leah Squires
Medicine Faculty Publications
Although the majority of HIV-infected patients who begin potent antiretroviral therapy should expect long-term virologic suppression, the realities in practice are less certain. Durability of viral suppression was examined to define the best timing of targeted adherence strategies and intensive viral load monitoring in an urban clinic population with multiple challenges to ART adherence. We examined the risk of viral rebound for patients who achieved two consecutive viral loads lower than the lower limit of quantification (LLOQ) within 390 days. For 791 patients with two viral loads below the LLOQ, viral rebound >LLOQ from the first viral load was 36.9 …